Overview
Translating Research Into Action for Diabetes (TRIAD) is a national multi-center study that was created to determine how managed care systems influence the processes and outcomes of diabetes care. The study will describe and evaluate the quality of care and life among people with diabetes through the help from 10 health plans and 68 provider groups.
Mission
The mission of TRIAD is twofold – (1) to improve the quality of care and the quality of life for people with diabetes and (2) to provide practical information on how to better implement effective treatments for diabetic patients in the United States managed care settings. We are doing this by carefully studying diabetic patients and their care within managed care settings and sharing our findings with physicians and health care organizations.
Collaborators
TRIAD includes six Translational Research Centers (TRCs). These centers initially collaborated with 10 health plans and 68 provider groups, which served approximately 180,000 people with diabetes. The health plans participating in TRIAD included staff model health maintenance organizations (HMO), network/IPA model HMOs, point of service (POS) plans, and preferred provider organizations (PPO). These plans included for profit, not-for-profit, Medicare, and Medicaid providers.
The 68 provider groups who contracted with TRIAD's partner health plans included independent practice associations (IPA) and medical groups. An IPA consists of physicians in independent offices who affiliate for purposes of contracting with managed care plans. Medical groups are organizations with shared overhead such as rent, administrative support staff, etc.
TRIAD has collaborated with the Veterans Health Administration (VHA) and the Social and Behavioral Research Institute (SBRI) in the past.
Many of the TRCs are now collaborating with other health plans as well as state Departments of Health funded by CDC, such as the Diabetes Prevention and Control Programs (DPCPs) in order to expand our audience.
Below is a list of additional organizations that individual TRCs are also partnering with to help disseminate study findings from TRIAD:
Indiana University:
- Diabetes Prevention and Control Program of Indiana
- Diabetes Prevention and Control Program of Minnesota
- Indiana CTSI (Clinical and Translational Sciences Institute)
- Indiana University Medical Group Primary Care
- Minnesota Diabetes Primary Prevention Initiative (DPPI)
- Regenstrief Institute
- ResNet - the Indiana University and IUMG Research Network
- The Indianapolis YMCAs
Kaiser Permanente Northern California:
Pacific Health Research Institute:
- State of Hawaii Diabetes Prevention and Control Program
University of California, Los Angeles:
University of Medicine and Dentistry of New Jersey:
- Capital Area Primary Care Research Network (CAPRICORN)
- New Jersey Diabetes Prevention and Control Program
- New Jersey Family Medicine Research Network (NJFMRN)
- Virginia-based Ambulatory Care Outcomes Research Network (ACORN)
University of Michigan:
- Michigan Association of Health Plans
- Michigan Diabetes Prevention and Control Program
- National Kidney Foundation of Michigan
Funding
TRIAD is supported by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and the National Institutes of Health's (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in Bethesda, Maryland.
For information on the Federal Policy for the Protection of Human Subjects, please click here.
